Krensavage Asset Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Krensavage Asset Management LLC
CRD #168976
SEC #801-78631
CIK #0001609251
AUM 300.2 M (2026-03-25)
Employees 4 (75% Investors, 0% Brokers)
Fees
Minimum
Phone212-888-1582
Address610 Fifth Avenue
New York, NY 10020
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
50040030020010002010201520212027
Fees and Compensation — Form ADV Part 2A (3/25/2026) [Brochure]
Item 5        Fees and Compensation
A.     ADVISORY FEES AND BILLING PROCEDURES
KAM receives a quarterly management fee (“Management Fee”) equal to 0.5% (2.0% per
annum) of each Fund’s net asset value as of the beginning of each calendar quarter. The
Management Fee is calculated and payable quarterly in advance, as of the first day of each
quarter. A pro rata portion of the Management Fee is charged to Limited Partners or
Shareholders on any amounts accepted by the Funds during a quarter. KAM or relevant
General Partner, in their sole discretion, may waive or reduce Management Fees, for any
Limited Partner or Shareholder in a Fund.
B.     OTHER FEES AND EXPENSES
The Funds paid for their own organizational and initial offering expenses and pay for their
own operating expenses (subject to a cap for Krensavage Partners, as specified in the
applicable Memorandum), including, but not limited to, operating expenses include, but are
not limited to, (i) all expenses incurred in connection with the ongoing offer and sale of
interests, including, but not limited to, printing of the offering documents and exhibits and
documentation of performance and the admission of investors, (ii) all operating expenses of
the Funds such as tax preparation fees, governmental fees and taxes, administrator fees,
accounting fees, costs of communications with investors, and ongoing legal, accounting,
auditing, bookkeeping, consulting and other professional fees and expenses, (iii) all
“Transaction Expenses” of the Funds (as defined below), and (iv) all fees and other expenses
incurred in connection with the investigation, prosecution or defense of any claims, assertion
of rights or pursuit of remedies, by or against the Funds, as each of the foregoing is further
described in each Fund’s Memorandum. “Transaction Expenses” consist of all Fund research,
trading and investment related costs and expenses (e.g., research reports, due diligence on
portfolio companies, brokerage commissions, margin interest, expenses related to short sales,
custodial and banking fees, clearing and settlement charges, fees for data and pricing
information, and trade routing and order management fees. Krensavage Offshore, as the
feeder fund into Krensavage Partners, will bear a pro rata portion of expenses of Krensavage
Partners (the master fund).

Expenses that are common to more than one of the Funds will generally be shared among the
applicable Funds pro rata according to the relative net asset values of each Fund or otherwise
as KAM determines to be equitable.
Investors may be subject to an “early withdrawal penalty” of 3% applicable to any capital
contribution that it withdraws prior to the first anniversary of such contribution.
The general partner and KAM will pay for their own administrative and overhead expenses
incurred in connection with providing services to the Funds.
KAM’s Pricing and Allocation Committee (the “PAC”) generally oversees issues related to Fund
expenses at its regular semi-annual meeting.
C.        REFUND POLICY
No part of the Management Fee will be refunded in the event that a Limited Partner
withdraws, or Shareholder redeems, whether voluntarily or involuntarily, all or any of the
value in the Limited Partner’s capital account or Shareholder’s shares during any quarter.
D.        OTHER COMPENSATION
KAM does not accept any other compensation other than the fees as described in Item 5 and
Account Minimums and Types of Clients — Form ADV Part 2A (3/25/2026) [Brochure]
Item 7        Types of Clients
KAM provides portfolio management services to the Funds only.
The minimum initial capital contribution for interests in Krensavage Partners is $500,000 and
the minimum initial subscription for shares in Krensavage Offshore is $500,000. KAM reserves
the right to reduce the minimum initial capital contribution and to accept subscriptions for
lesser amounts. Except as may be required by law, there are no minimum requirements for
maintaining an interest in the Funds.
Note that a Fund may from time-to-time enter into side letter agreements or other similar
agreements (collectively, "Side Letters") with one or more investors in a Fund which provide
them with additional and/or different rights (including, without limitation, with respect to
management fees, performance allocations, early withdrawal penalty, withdrawals, access to
information and minimum investment amounts) from other investors. The Fund’s General
Partner will not be required to notify any or all of the other investors of any such Side Letters
or any of the rights and/or terms or provisions thereof, nor will the General Partner be
required to offer such additional and/or different rights and/or terms to any or all of the other
investors.
CIK Period
0001609251
Sector Form 13F Holdings Value ($M)
United Therapeutics Corp 50.0
Enanta Pharmaceuticals Inc 36.2
Jazz Pharmaceuticals Inc 31.7
BioMarin Pharmaceutical Inc 29.6
Exelixis Inc 17.8
Sanofi 15.6
Supernus Pharmaceuticals Inc 14.5
Indivior PLC 10.3
Ultragenyx Pharmaceutical Inc 8.2
Vanda Pharmaceuticals Inc 8.2
Embecta Corp 6.5
GlaxoSmithKline PLC 5.3
Biontech SE 5.3
Alkermes PLC 3.8
Biogen IDEC Inc 3.7
Regeneron Pharmaceuticals Inc 3.1
Ardelyx Inc 3.0
Inmode Ltd 1.7
Evolus Inc 0.6
Abbott Laboratories 0.5
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold AUM
HF Krensavage Partners TOO LP [2016-03-18] 79.9 M 19.9 M
Filed 2025-05-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $100,892 · Net Assets Decline to Disclose
HF Krensavage Offshore Fund Ltd [2015-04-01] 199.6 M 79.1 M
Filed 2025-06-30 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Commission $13,150 · Net Assets Decline to Disclose
HF Krensavage Partners LP [2013-09-24] 199.6 M 284.8 M
Filed 2025-06-30 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Commission $13,150 · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 300.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 2 300.2
By Discretionary
Discretionary 2 300.2
Non-Discretionary 0 0.0
Total 2 300.2
By Non-United States Persons
Non-United States Persons 28.2
United States Persons 272.0
Total 2 300.2
Form D Directors Role # Filings # Firms 2011 - 2026
Krensavage Asset Management LLC Promoter 3 2
Michael Krensavage Executive Officer 3 2
Paul Paolino Executive Officer 1 1
Krensavage Advisors Too LLC Promoter 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001609251]
SC 13D [0001609251]
SC 13G [0001609251]
Form 13D/13G Filer Form 13D/13G Subject Filed
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2024-02-27]
Krensavage Asset Management LLC RTI Surgical Inc [2019-02-14]
Krensavage Asset Management LLC Aviragen Therapeutics Inc [2018-02-15]
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2017-02-15]
Krensavage Asset Management LLC Aviragen Therapeutics Inc [2017-02-14]
Krensavage Asset Management LLC RTI Surgical Inc [2015-11-09]
Firm Profile (Form ADV)
Discretionary AUM$0.1B
ServesInstitutional
Fund TypesHedge Fund
Comparable Firms State AUM
Praxis Capital Management LLC
IL 301.4 M
Parsow Management LLC
301.2 M
Triveni Capital Investments LP
CT 300.9 M
Castle Ridge Asset Management Limited
300.8 M
Wellspring GBL LLC
NY 300.5 M
Panoramic Capital LLC
CA 299.6 M
Greenhaven Road Investment Management LP
CT 299.5 M
Polpo Capital Management LLC
299.5 M
MQS Management LLC
NY 299.4 M
Osmosis Investment Management US LLC
298.9 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com